Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC

NCT02716038 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: MPDL3280A
DRUG: Carboplatin
DRUG: Nab-paclitaxel

Sponsor

Columbia University

Collaborators

[object Object]
[object Object]